One in four women with the most aggressive form of ovarian cancer could receive an earlier diagnosis through fast-track testing.
Researchers at the University of Birmingham found that symptom triggered testing prioritises blood tests and ultrasounds for women who have symptoms such as bloating, bowel changes, appetite changes or abdominal pain, leading to timely diagnosis.
Professor Sudha Sundar, of the Pan Birmingham Gynaecological Cancer Centre and author of the study, said: 'Although this [symptom triggered testing] has existed since 2011, it's never really been clear-cut if this is useful for patients. What our study has shown is that, yes, you can pick it up, but you can also pick it up early. Potentially we are not just able to identify women with cancer but pick up ovarian cancer at a stage where it makes a very big difference for the individual.’
- Retail loyalty card data could identify ovarian cancer earlier
- NHS genomic testing helping to diagnose thousands with cancer-causing syndrome
- Cancer deaths plummet in middle-aged patients, but challenges remain warns charity
Over 4,000 women in the UK die from ovarian cancer each year, according to data from the Cancer Research UK. One in 10 cases of ovarian cancer are preventable, and earlier diagnosis can lead to better treatment and longer survival rates.
The researchers looked at data from the Refining Ovarian Cancer Test accuracy Scores (ROCkeTS) study, which involved 24 hospitals across the UK. Of the 1,741 patients who had their ovarian cancer test fast-tracked, 119 were diagnosed with high grade serous ovarian cancer, one of the more deadly variations of the disease.
Over a quarter (25.2%) of patients included in the study had been diagnosed with stage one or two ovarian cancer, and of these women, 93% went on to survive for more than five years. The fast-track testing enabled 78 out of 119 access surgery to remove as many cancer cells from the abdomen as possible, while 36 patients were given chemotherapy before surgery.
Professor Sundar said that she hopes the findings will raise awareness for more GPs to issue such tests for ovarian cancer and encourage women with potential symptoms to get them checked out. ‘We also hope women who have these symptoms will know something is not right and will speak to their GP,’ she said.